183 related articles for article (PubMed ID: 17700357)
1. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
2. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Nachon F; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2008 Mar; 18(3):213-8. PubMed ID: 18300943
[TBL] [Abstract][Full Text] [Related]
3. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Manoharan I; Wieseler S; Layer PG; Lockridge O; Boopathy R
Pharmacogenet Genomics; 2006 Jul; 16(7):461-8. PubMed ID: 16788378
[TBL] [Abstract][Full Text] [Related]
5. Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells.
Sudo K; Maekawa M; Akizuki S; Magara T; Ogasawara H; Tanaka T
Biochem Biophys Res Commun; 1997 Nov; 240(2):372-5. PubMed ID: 9388484
[TBL] [Abstract][Full Text] [Related]
6. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
Biberoglu K; Tacal Ö; Akbulut H
Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
[TBL] [Abstract][Full Text] [Related]
7. Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample.
Souza RL; Mikami LR; Maegawa RO; Chautard-Freire-Maia EA
Mol Genet Metab; 2005 Apr; 84(4):349-53. PubMed ID: 15781196
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
9. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase.
Sezgin Z; Biberoglu K; Chupakhin V; Makhaeva GF; Tacal O
Arch Biochem Biophys; 2013 Apr; 532(1):32-8. PubMed ID: 23353050
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
Primo-Parmo SL; Bartels CF; Wiersema B; van der Spek AF; Innis JW; La Du BN
Am J Hum Genet; 1996 Jan; 58(1):52-64. PubMed ID: 8554068
[TBL] [Abstract][Full Text] [Related]
12. Tetramerization domain of human butyrylcholinesterase is at the C-terminus.
Blong RM; Bedows E; Lockridge O
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):747-57. PubMed ID: 9581552
[TBL] [Abstract][Full Text] [Related]
13. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
14. Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers.
Li H; Schopfer LM; Masson P; Lockridge O
Biochem J; 2008 Apr; 411(2):425-32. PubMed ID: 18076380
[TBL] [Abstract][Full Text] [Related]
15. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of recombinant human butyrylcholinesterase.
Yuan HJ; Yu WY; Shi CH; Sun MJ
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):74-80. PubMed ID: 10437130
[TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase.
Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Chilukuri N; Duysen EG; Parikh K; Sun W; Doctor BP; Lockridge O; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):327-31. PubMed ID: 18499092
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase: phenotyping and genotyping.
Goodall R;
Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
